[go: up one dir, main page]

FI920737A7 - Terapeutiska peptider - Google Patents

Terapeutiska peptider Download PDF

Info

Publication number
FI920737A7
FI920737A7 FI920737A FI920737A FI920737A7 FI 920737 A7 FI920737 A7 FI 920737A7 FI 920737 A FI920737 A FI 920737A FI 920737 A FI920737 A FI 920737A FI 920737 A7 FI920737 A7 FI 920737A7
Authority
FI
Finland
Prior art keywords
therapeutic peptides
peptides
therapeutic
Prior art date
Application number
FI920737A
Other languages
English (en)
Finnish (fi)
Other versions
FI920737A0 (fi
Inventor
David H Coy
Sun Hyuk Kim
Jacques-Pierre Moreau
Original Assignee
The Administrators Of The Tulane Educational Fund
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrators Of The Tulane Educational Fund, Biomeasure Inc filed Critical The Administrators Of The Tulane Educational Fund
Publication of FI920737A0 publication Critical patent/FI920737A0/fi
Publication of FI920737A7 publication Critical patent/FI920737A7/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57572Gastrin releasing peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI920737A 1989-08-21 1990-08-17 Terapeutiska peptider FI920737A7 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39716989A 1989-08-21 1989-08-21
US07/502,438 US5084555A (en) 1989-08-21 1990-03-30 An octapeptide bombesin analog
PCT/US1990/004646 WO1991002746A1 (en) 1989-08-21 1990-08-17 Therapeutic peptides

Publications (2)

Publication Number Publication Date
FI920737A0 FI920737A0 (fi) 1992-02-20
FI920737A7 true FI920737A7 (sv) 1992-02-20

Family

ID=27015776

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920737A FI920737A7 (sv) 1989-08-21 1990-08-17 Terapeutiska peptider

Country Status (12)

Country Link
US (1) US5084555A (sv)
EP (1) EP0489089B1 (sv)
JP (1) JPH04506664A (sv)
AT (1) ATE139540T1 (sv)
AU (1) AU648037B2 (sv)
CA (1) CA2064896A1 (sv)
DE (1) DE69027533T2 (sv)
DK (1) DK0489089T3 (sv)
ES (1) ES2090140T3 (sv)
FI (1) FI920737A7 (sv)
NO (1) NO302619B1 (sv)
WO (1) WO1991002746A1 (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) * 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
US6218364B1 (en) 1988-06-20 2001-04-17 Scott L. Harbeson Fluorinated neurokinin A antagonists
US5767236A (en) * 1990-05-09 1998-06-16 Biomeasure, Inc. Linear therapeutic peptides
US5620959A (en) * 1990-07-31 1997-04-15 Glaxo Wellcome Inc. Bombesin antagonists
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
EP0639981A4 (en) * 1992-05-08 1995-06-28 Univ Jefferson ANALOGS OF THE IGF FACTOR (01/18/94).
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5650395A (en) * 1995-03-13 1997-07-22 Hurel; Steven Treatment of pulmonary hypertension
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6989371B1 (en) 1996-08-16 2006-01-24 Dabur Research Foundation Bombesin analogs for treatment of cancer
GB0009918D0 (en) * 2000-04-20 2000-06-07 Rose Keith Covalent capture facilitating purification of polypeptides
US20030013637A1 (en) * 2001-05-18 2003-01-16 Hideto Ikushima Novel anti-autoimmune composition by inhibition of GRF action
AU2003262878A1 (en) * 2002-08-26 2004-03-11 Wisconsin Alumni Research Foundation HETEROGENEOUS FOLDAMERS CONTAINING Alpha, Beta, AND/OR Gamma-AMINO ACIDS
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US20060239923A1 (en) * 2003-01-13 2006-10-26 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8709998B2 (en) 2003-04-22 2014-04-29 Ipsen Pharma S.A.S. Peptide vectors
US8101580B2 (en) 2005-04-21 2012-01-24 Astellas Pharma Inc. Therapeutic agent for irritable bowel syndrome
CA2858907A1 (en) * 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents
MX2009003617A (es) * 2006-10-02 2009-04-22 Bayer Schering Pharma Ag Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet).
WO2008104203A2 (en) * 2007-03-01 2008-09-04 Bayer Schering Pharma Aktiengesellschaft 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
ES2732205T3 (es) 2008-06-12 2019-11-21 Ipsen Bioinnovation Ltd Proteínas de fusión para uso en el tratamiento del cáncer
BRPI0915888E2 (pt) 2008-06-12 2020-09-01 Syntaxin Ltd polipetídeo, seu método de ativação, sequência de ácido nucléico codificando o mesmo e seu uso
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP2198878A1 (en) 2008-12-18 2010-06-23 University Of Miami Polypeptide bombesin antagonists
EP3920961A4 (en) 2019-02-08 2022-12-14 United States Government as represented by the Department of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
EP4483959A3 (en) * 2019-05-21 2025-06-04 Eyebio Korea Novel peptide compound or pharmaceutically acceptable salt thereof
WO2021011874A1 (en) 2019-07-18 2021-01-21 University Of Miami Ghrh antagonists for use in a method of treating sarcoidosis
CN116333041A (zh) * 2023-04-10 2023-06-27 湖南中晟全肽生化有限公司 一种激活grp受体的多肽化合物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) * 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties
US4650661A (en) * 1982-09-15 1987-03-17 Aktiebolaget Hassle Enzyme inhibitors
DE3378121D1 (de) * 1982-10-18 1988-11-03 Ici Plc Peptide and pseudopeptide derivatives
IT1190389B (it) * 1985-09-19 1988-02-16 Eniricerche Spa Esapeptidi ad attivita' ipotensiva
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JP2795449B2 (ja) * 1987-09-24 1998-09-10 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ペプチド
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds

Also Published As

Publication number Publication date
WO1991002746A1 (en) 1991-03-07
DE69027533D1 (de) 1996-07-25
FI920737A0 (fi) 1992-02-20
AU6294090A (en) 1991-04-03
ATE139540T1 (de) 1996-07-15
US5084555A (en) 1992-01-28
CA2064896A1 (en) 1991-02-22
DK0489089T3 (da) 1996-07-29
NO920678D0 (no) 1992-02-20
EP0489089A4 (en) 1992-06-24
EP0489089B1 (en) 1996-06-19
NO302619B1 (no) 1998-03-30
ES2090140T3 (es) 1996-10-16
EP0489089A1 (en) 1992-06-10
DE69027533T2 (de) 1996-12-19
AU648037B2 (en) 1994-04-14
JPH04506664A (ja) 1992-11-19
NO920678L (no) 1992-04-06

Similar Documents

Publication Publication Date Title
FI920737A7 (sv) Terapeutiska peptider
DK97790A (da) Renin-inhiberende peptider
FI913899A7 (sv) Terapeutiska aerosolblandningar
FI906367A0 (fi) Terapeutiska nukleosider.
DK540289D0 (da) Protein
FI892507L (fi) Terapeutiska peptider.
DK111489D0 (da) Peptider
FI914995A7 (sv) Terapeutiskt ämne
DK197989A (da) Peptidanaloger
FI904854A0 (fi) Terapeutiska nukleosider.
FI905741A7 (sv) Peptider
DK425789D0 (da) Vaccinale polypeptider
DK354487A (da) Oncogen-relaterede peptider
FI930674L (fi) Terapeutiska aemnen
KR900700503A (ko) 펩티드
FI894321A7 (sv) Terapeutiska ämnen
FI931071L (fi) Terapeutiska aemnen
DK428589A (da) Vaccinale polypeptider
NO177858C (no) Peptid
FI901547A7 (sv) Neurotropiska peptider
KR900015343U (ko) 안마겸용 때밀이 장치
DK381789D0 (da) Peptider
KR900016687U (ko) 안마구
KR910010852U (ko) 안마기
DK51188D0 (da) Peptider

Legal Events

Date Code Title Description
FD Application lapsed